Cargando…

PS92. Serum BDNF and GDNF levels before and after the 12-week antidepressant treatments among outpatients with major depressive disorder

Detalles Bibliográficos
Autores principales:	Lee, Bun-Hee, Park, Young-Min
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2016
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5616689/ http://dx.doi.org/10.1093/ijnp/pyw043.092

Ejemplares similares

Alterations in Serum BDNF and GDNF Levels after 12 Weeks of Antidepressant Treatment in Female Outpatients with Major Depressive Disorder
por: Park, Young-Min, et al.
Publicado: (2018)

The Roles of BDNF in the Pathophysiology of Major Depression and in Antidepressant Treatment
por: Lee, Bun-Hee, et al.
Publicado: (2010)

Serum BDNF and GDNF in Chinese male patients with deficit schizophrenia and their relationships with neurocognitive dysfunction
por: Tang, Xiaowei, et al.
Publicado: (2019)

PS97. Serum Cytokine Levels in Major Depressive Disorder and Its Role in Antidepressant Response
por: Myung, Woojae, et al.
Publicado: (2016)

Predictors of Cognitive Improvement during 12 Weeks of Antidepressant Treatment in Patients with Major Depressive Disorder
por: Lee, Jeong-Ok, et al.
Publicado: (2018)

PS82. Does Serum Amyloid ß-Protein predict the Response to Antidepressant treatment in Major Depression?
por: Inoue, Megumi, et al.
Publicado: (2016)

The serum protein levels of the tPA–BDNF pathway are implicated in depression and antidepressant treatment
por: Jiang, H, et al.
Publicado: (2017)

The Strategy of Combining Antidepressants in the Treatment of Major Depression: Clinical Experience in Spanish Outpatients
por: Martín-López, Luis M., et al.
Publicado: (2011)

Effects of Antidepressant Treatment on Neurotrophic Factors (BDNF and IGF-1) in Patients with Major Depressive Disorder (MDD)
por: Mosiołek, Anna, et al.
Publicado: (2021)

Changes in Plasma TPH2, GDNF, Trk-b, BDNF, and proBDNF in People Who Died by Suicide
por: Liu, Xiaoyu, et al.
Publicado: (2023)

Minor Immunoreactivity in GDNF-, BDNF-, or NT-3-Treated Substantia Nigra Allografts
por: Shinoda, Masaki, et al.
Publicado: (1997)

BDNF, GDNF, NGF and Klotho levels and neurocognitive functions in acute term of schizophrenia
por: Turkmen, Betul Aslan, et al.
Publicado: (2021)

The Role of Metals in the Neuroregenerative Action of BDNF, GDNF, NGF and Other Neurotrophic Factors
por: Nicoletti, Vincenzo Giuseppe, et al.
Publicado: (2022)

Serum BDNF Levels are Not Associated with the Antidepressant Effects of Nonconvulsive Electrotherapy
por: Zheng, Wei, et al.
Publicado: (2020)

PS129. Low TNFAIP3 was normalized with antidepressant in patients with major depressive disorder
por: Hung, Yi-Yung
Publicado: (2016)

Serum BDNF Levels in Relation to Illness Severity, Suicide Attempts, and Central Serotonin Activity in Patients with Major Depressive Disorder: A Pilot Study
por: Park, Young-Min, et al.
Publicado: (2014)

Serum proBDNF/BDNF and response to fluvoxamine in drug-naïve first-episode major depressive disorder patients
por: Yoshimura, Reiji, et al.
Publicado: (2014)

Interplay of BDNF and GDNF in the Mature Spinal Somatosensory System and Its Potential Therapeutic Relevance
por: Ferrini, Francesco, et al.
Publicado: (2021)

SuPAR in major depression: Association with 26 weeks antidepressant response and 10-year depression outcomes
por: Haupt, T.H., et al.
Publicado: (2023)

Enhanced antidepressant effects of BDNF-quercetin alginate nanogels for depression therapy
por: Xu, Dong, et al.
Publicado: (2023)

Barriers and facilitators of adherence to antidepressants among outpatients with major depressive disorder: A qualitative study
por: Ho, Siew Ching, et al.
Publicado: (2017)

The Influence of Neurotrophic Factors BDNF and GDNF Overexpression on the Functional State of Mice and Their Adaptation to Audiogenic Seizures
por: Kustova, Angelina O., et al.
Publicado: (2022)

Suicide and Neurotrophin Factors: A Systematic Review of the Correlation between BDNF and GDNF and Self-Killing
por: De Simone, Stefania, et al.
Publicado: (2022)

Effects of BDNF Polymorphisms on Antidepressant Action
por: Tsai, Shih-Jen, et al.
Publicado: (2010)

PS102. Apathy in elderly depression and the antidepressant response
por: Shimano, Takahisa, et al.
Publicado: (2016)

PS90. Differences in hypochondriasis between Korean and American outpatients with major depressive disorder
por: Kim, Jiyeon, et al.
Publicado: (2016)

PS76. Effect of antidepressant therapy on white matter in patients with first-episode major depressive disorder
por: Lee, Chun-Te, et al.
Publicado: (2016)

Serum Cytokine Levels in Major Depressive Disorder and Its Role in Antidepressant Response
por: Myung, Woojae, et al.
Publicado: (2016)

PS training plan 1991-92
por: Dekkers, D
Publicado: (1991)

Noncontinuous use of antidepressant in adults with major depressive disorders – a retrospective cohort study
por: Yau, Wai-Yin, et al.
Publicado: (2014)

EXM 92-23 12/11/92
por: Daems, G
Publicado: (1992)

EXM 92-25 03/12/92
por: Daems, G
Publicado: (1992)

Resveratrol Produces Neurotrophic Effects on Cultured Dopaminergic Neurons through Prompting Astroglial BDNF and GDNF Release
por: Zhang, Feng, et al.
Publicado: (2012)

Ibogaine Administration Modifies GDNF and BDNF Expression in Brain Regions Involved in Mesocorticolimbic and Nigral Dopaminergic Circuits
por: Marton, Soledad, et al.
Publicado: (2019)

Decreased Serum Levels of Mature Brain-Derived Neurotrophic Factor (BDNF), but Not Its Precursor proBDNF, in Patients with Major Depressive Disorder
por: Yoshida, Taisuke, et al.
Publicado: (2012)

Meta-analyses of comparative efficacy of antidepressant medications on peripheral BDNF concentration in patients with depression
por: Zhou, Chanjuan, et al.
Publicado: (2017)

Plasma BDNF concentrations and the antidepressant effects of six ketamine infusions in unipolar and bipolar depression
por: Zheng, Wei, et al.
Publicado: (2021)

PS188. Predict value of functional topological features for early response to antidepressant treatment in major depressive disorder
por: Hou, Zhenghua, et al.
Publicado: (2016)

The Combination of Serum BDNF, Cortisol and IFN-Gamma Can Assist the Diagnosis of Major Depressive Disorder
por: Chen, Suzhen, et al.
Publicado: (2021)

Changes in the serum levels of inflammatory cytokines in antidepressant drug-naïve patients with major depression
por: Zou, Wei, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_1phei9qm10cp4cn14hdi88mrqs